Comments
Loading...

Evolent Health

EVHNYSE
Logo brought to you by Benzinga Data
$11.41
0.232.06%
At close: -
$11.35
-0.06-0.53%
After Hours: Dec 20, 4:24 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$59.00
Lowest Price Target1
$15.00
Consensus Price Target1
$33.71

Evolent Health (NYSE:EVH) Stock, Analyst Ratings, Price Targets, Forecasts

Evolent Health Inc has a consensus price target of $33.71 based on the ratings of 17 analysts. The high is $59 issued by Cowen & Co. on January 30, 2023. The low is $15 issued by JP Morgan on November 22, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Oppenheimer, and Citigroup on November 22, 2024, November 18, 2024, and November 13, 2024, respectively. With an average price target of $21.33 between JP Morgan, Oppenheimer, and Citigroup, there's an implied 87.96% upside for Evolent Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
4
Aug
3
Oct
6
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Oppenheimer
Citigroup
RBC Capital
Barclays

1calculated from analyst ratings

Analyst Ratings for Evolent Health

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Evolent Health (EVH) stock?

A

The latest price target for Evolent Health (NYSE:EVH) was reported by JP Morgan on November 22, 2024. The analyst firm set a price target for $15.00 expecting EVH to rise to within 12 months (a possible 32.16% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Evolent Health (EVH)?

A

The latest analyst rating for Evolent Health (NYSE:EVH) was provided by JP Morgan, and Evolent Health maintained their overweight rating.

Q

When was the last upgrade for Evolent Health (EVH)?

A

The last upgrade for Evolent Health Inc happened on August 9, 2024 when Truist Securities raised their price target to $33. Truist Securities previously had a hold for Evolent Health Inc.

Q

When was the last downgrade for Evolent Health (EVH)?

A

The last downgrade for Evolent Health Inc happened on November 8, 2024 when Stephens & Co. changed their price target from N/A to $16 for Evolent Health Inc.

Q

When is the next analyst rating going to be posted or updated for Evolent Health (EVH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evolent Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evolent Health was filed on November 22, 2024 so you should expect the next rating to be made available sometime around November 22, 2025.

Q

Is the Analyst Rating Evolent Health (EVH) correct?

A

While ratings are subjective and will change, the latest Evolent Health (EVH) rating was a maintained with a price target of $45.00 to $15.00. The current price Evolent Health (EVH) is trading at is $11.35, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch